WIPO Traditional Knowledge Committee Agrees To Intensify Text-Based Negotiations 08/05/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment A meeting of the World Intellectual Property Organization committee on traditional knowledge, traditional cultural expressions and genetic resources drew to a close today with an unusual ending: applause, and an agreement.
Coordination Mechanism Adopted For WIPO Development Agenda Implementation 01/05/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment A mechanism to watch the continuing implementation of development-oriented principles into the World Intellectual Property Organization’s work has now been found. For many, the Development Agenda is the most important agreement in WIPO’s recent past, and the mechanism – which will monitor, assess and report on its implementation – was a critical area of importance in ensuring it reaches its full potential.
Global IP Enforcement Push Impacting Consumer Access, 2010 IP Watchlist Finds 29/04/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment The second edition of the Consumers International IP Watchlist has been published, with the conclusion that consumers are bearing collateral damage to the enforcement push by entertainment and media lobby groups encouraging stringent national legislations. Copyright laws and enforcement are changing, but mostly for the benefit of right holders, said the advocate group which encourages copyright exceptions.
El Ecuador concede primera licencia obligatoria para medicamentos contra el VIH/SIDA 26/04/2010 by Catherine Saez, Intellectual Property Watch 4 Comments Este mes, el Ecuador concedió su primera licencia obligatoria para un producto farmacéutico patentado, desde que el año pasado declarara que utilizaría normas internacionales que permiten tal concesión. Esta acción ya le ha aportado al país ahorros sustanciales debido a la nueva competencia, según la oficina de propiedad intelectual ecuatoriana. Otros países latinoamericanos podrían verse atraídos por las perspectivas de precios de medicamentos más bajos, según dejaron trascender algunos defensores. El titular de los derechos se manifestó decepcionado por la decisión.
Medicrime: Another Anti-Counterfeiting Convention Emerges In Europe 24/04/2010 by Monika Ermert for Intellectual Property Watch 3 Comments While the Anti-Counterfeiting Trade Agreement (ACTA) is getting a lot of attention with its draft consolidated version just published, there is another convention dealing with one major aspect it was always said ACTA would tackle. The Medicrime Convention of the Council of Europe sets the first international standard for criminalising the manufacturing and distribution of counterfeited medicine risking public health. And Medicrime will overtake ACTA, as the draft convention text is ready to be signed by the Committee of Ministers in May and be opened for signature in November.
Biodiversity: Bountiful Source For Cosmetics, But Needs Respect, Group Says 21/04/2010 by Catherine Saez, Intellectual Property Watch 3 Comments PARIS- The cosmetics industry is about beauty, but it is also increasingly about biodiversity as consumers show a growing awareness of environmental issues and the loss of biodiversity. As a wishful wink to the 10th meeting of the UN Convention on Biological Diversity (CBD) in Nagoya in October 2010, the Union for Ethical Biotrade (UEBT) held a conference at the Palais de Tokyo in Paris on 15 April.
Geneva Health Forum Addresses Biotech, Trade, Pandemic Flu 21/04/2010 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Biotechnology, international trade, and pandemic influenza were among the topics discussed at the outset of this year’s Geneva Health Forum.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
在WHO就假冒伪劣药品问题吹风会上观点激烈交锋 03/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment 世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Débat houleux lors d’une réunion d’information organisée par l’OMS sur les médicaments contrefaits 01/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.